UK's Oxford Biomedica confirms unsolicited bid from funds managed by EQT

Core Viewpoint - Oxford Biomedica has received an unsolicited cash offer from EQT-managed funds for all of its shares [1] Company Summary - Oxford Biomedica is a British manufacturer specializing in cell and gene therapy [1]